test

Mark N. Lampert

@Bvf Inc Il

Latest period2024 - Q3ReportedManaged Assets$3.418BTotal holdings55
Assets growth rate-4.19%Assets growth rate (2-Q avg)-3.05%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Bvf Inc Il's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 55 positions.

Assets under management

The assets under management (AUM) of Bvf Inc Il over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.418B in assets, with a quarterly growth rate of -4.19% and a 2-quarter average growth rate of -3.05%. The portfolio is managed by Mark N. Lampert, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PTGXProtagonist Therapeutics Inc
Recent Activity
Decreased -44.26%
2.44%
$83.258M
1.85M shares@ $45.0 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 88.22%
2.34%
$79.806M
7.383M shares@ $10.81 avg price
ACIUAc Immune Sa
Recent Activity
Increased 3.66%
2.16%
$73.795M
19.522M shares@ $3.78 avg price
GHRSGh Research Plc
Recent Activity
2.04%
$69.577M
10.4M shares@ $6.69 avg price
KURAKura Oncology Inc
Recent Activity
Decreased -17.4%
1.93%
$65.884M
3.372M shares@ $19.55 avg price
THRDThird Harmonic Bio Inc
Recent Activity
1.74%
$59.158M
4.366M shares@ $13.55 avg price
IONSIonis Pharmaceuticals Inc
Recent Activity
Decreased -54.43%
1.71%
$58.162M
1.452M shares@ $40.07 avg price
ZYMEZymeworks Inc
Recent Activity
Decreased -21.5%
1.7%
$57.83M
4.608M shares@ $12.55 avg price
EPIXEssa Pharma Inc
Recent Activity
1.56%
$53.017M
8.749M shares@ $6.07 avg price
AGIOAgios Pharmaceuticals Inc
Recent Activity
1.55%
$52.876M
1.19M shares@ $44.43 avg price